-- Pall, Smith & Wesson, Zeltiq, Zogenix: U.S. Equity Movers
-- B y   I n y o u n g   H w a n g
-- 2012-03-09T21:20:02Z
-- http://www.bloomberg.com/news/2012-03-08/green-mountain-heckmann-texas-instruments-u-s-equity-preview.html
Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses and prices are as of 4 p.m. in  New York .  3SBio Inc. (SSRX)   advanced 18 percent, the most since
November 2007, to $14.19. The Chinese biotechnology company
posted fourth-quarter earnings excluding some items that beat
the average analyst estimate by 16 percent, according to data
compiled by Bloomberg.  Body Central Corp. (BODY)   fell 6.8 percent, the most
since Aug. 16, to $26.75. The women’s clothing retailer forecast
2012 revenue of $348 million at most, falling short of the
average analyst estimate of $355 million in a Bloomberg survey.  Cooper Cos. (COO)   rose 3.8 percent to $81.96, the
highest price since Sept. 20. The maker of  contact lenses 
reported first-quarter earnings of $1.12 a share, beating the
average analyst estimate of $1.04.  DR Horton Inc. (DHI)   climbed 6.4 percent, the second-
biggest jump in the Standard & Poor’s 500 Index, to $15.49. The
largest U.S. homebuilder by volume was lifted to outperform from
neutral at Credit Suisse Group AG, which cited increased buyer
traffic in a monthly survey of real estate agents. An outperform
rating means the stock’s returns are expected to exceed its
benchmark’s by at least 10 percent in the next year.  Dynegy Inc. (DYN)   slumped 36 percent, the biggest drop
in the Russell 2000 Index, to 76 cents. The independent power
producer’s transfer of coal-fired  power plants  from a unit it
later put into bankruptcy was fraudulent and harmed creditors, a
court-ordered investigation found.  Green Mountain Coffee Roasters Inc. (GMCR)   plunged 16
percent, the most in the Russell 1000 Index, to $52.59.
 Starbucks Corp. (SBUX)   said it plans to start selling a
single-cup coffee system in a bid to expand beyond its
partnership with the Waterbury, Vermont-based specialty coffee
and coffee maker company. Starbucks rose 2.9 percent to $51.84.  Heckmann Corp. (HEK)   decreased 9.6 percent, the most
since May 2009, to $4.78. The provider of water treatment and
disposal services reported fourth-quarter revenue of $51.7
million, missing the average analyst estimate of $54.5 million.
The company also said it will acquire Thermo Fluids Inc. for
$245 million in cash and stock.  Molycorp Inc. (MCP)   climbed 19 percent, the biggest
rally in the Russell 1000 Index, to $30.89. The owner of the
largest rare-earth deposit outside of  China  agreed to buy
Canada’s  Neo Material Technologies Inc. (NEMFF)   for about
C$1.3 billion ($1.3 billion) to increase Chinese sales and gain
technology used to make magnets.  Neo Material rallied 37 percent to $11.03.  Pall Corp. (PLL)   fell 3.1 percent, the most in the
Standard & Poor’s 500 Index, to $59.30. The supplier of filters
for drugmakers and refineries was cut to neutral from outperform
by Wedbush Securities, citing softness in markets including
China.  Quest Software Inc. (QSFT)   gained 24 percent, the most
since 2000, to $24.07. The developer of database-management
programs agreed to be taken private by Insight Venture Partners
in a deal valuing the company at about $2 billion. Stockholders
will get $23 a share.  Smith & Wesson Holding Corp. (SWHC)   surged 23 percent,
the most since November 2008, to $6.95. The handgun manufacturer
boosted its full-year sales forecast as third-quarter profit
beat analysts’ estimates.  Sprint Nextel Corp. (S)   rallied 6.9 percent, the biggest
gain in the Standard & Poor’s 500 Index, to $2.78. The request
by regulators for  Verizon Wireless  and cable operators led by
Comcast Corp. to provide more data on the companies’ proposed
$3.6 billion airwaves deal appears to be “a partial victory”
for smaller wireless operators such as Sprint, Stifel Nicolaus &
Co. said in a note.  TPC Group Inc. (TPCG)   climbed 9 percent to $41.88, the
highest price since July 26. The maker of petrochemical-derived
products reported a smaller fourth-quarter loss than analysts
estimated.  Zeltiq Aesthetics Inc. (ZLTQ)  (ZLTQ US) rose 18 percent, the most
since Oct. 19, to $6.70. The Pleasanton, California-based maker
of fat-reduction technology was rated as a new buy by Canaccord
Financial Inc. with a 12-month price estimate of $10, citing the
non-invasive fat reduction industry as a growth opportunity.  Zogenix Inc. (ZGNX)   fell 18 percent, the most since it
went public in November 2010, to $2.03. The specialty
pharmaceutical company said 2012 revenue will be $45.5 million
to $48.6 million, missing the average analyst estimate of $64.9
million in data compiled by Bloomberg.  To contact the reporter on this story:
Inyoung Hwang in New York at 
 ihwang7@bloomberg.net .  To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  